Cingulate will use the money — delivered in three $1 million tranches — to help develop its third drug, which targets an $11.6 billion global market.Cingulate wins $3M from private foundation to help develop third time-release drug
Cingulate will use the money — delivered in three $1 million tranches — to help develop its third drug, which targets an $11.6 billion global market.